arrow
A

Anuradha Chandramohan

christian medical college vellore
H指数:21
被引数:1,534

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A decision-support tool for management of advanced epithelial ovarian cancer in a single centre in India (CT PAUSE Nomogram): a prospective Study (2022–2024)

印度单一中心晚期上皮性卵巢癌管理决策支持工具(CT PAUSE列线图):一项前瞻性研究(2022–2024)

2026-04-290
OAAI
Clinical Profile, Outcomes, and Predictors of Malignant Pheochromocytoma and Paraganglioma: Insights From a Single-Center Cohort

临床特征、结局及恶性嗜铬细胞瘤和副神经节瘤的预测因素:单中心队列研究的见解

2025-07-300
PRE
DOES BASELINE PTH INFLUENCE RECOVERY OF BONE MINERAL DENSITY, TRABECULAR BONE SCORE AND BONE TURNOVER MARKERS? A PROSPECTIVE STUDY FOLLOWING CURATIVE PARATHYROIDECTOMY IN PRIMARY HYPERPARATHYROIDISM
2020-12-011
PRE
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial

替西罗莫司与帕唑帕尼 (TemPa) 在晚期透明细胞肾细胞癌和低风险特征患者中的比较: 一项随机II期试验

2020-10-0113
OAAI
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors

一线免疫检查点抑制剂后接受二线vegfr-tki治疗的转移性透明细胞肾细胞癌患者的预后

2019-06-0196
OAAI